Listen to this episode of Longevity by Design on Apple Podcasts, Spotify, and YouTube.
In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Louise Hecker, Associate Professor of Medicine at Baylor College of Medicine. Together, they dive into Louise’s recent research exploring how psilocybin, the active compound in psychedelic mushrooms, may influence aging biology at the cellular and organismal level.
Louise shares the story behind her curiosity about psilocybin, sparked by conversations with a friend and fueled by a lack of scientific answers. She explains how her team overcame regulatory hurdles to study the effects of psilocybin on human cells and aging mice. Their findings showed that psilocybin extended cellular lifespan and reduced hallmarks of aging, such as oxidative stress and DNA damage. In mice, regular dosing improved survival, reversed visible signs of aging, and affected organs beyond the brain.
The conversation also covers the challenges of translating these findings into humans, the need for more research on dosing and safety, and the importance of funding in moving this field forward. Louise encourages listeners to stay curious, think beyond established paths, and keep an open mind as new questions and discoveries emerge in the science of aging.
💡 Name: Dr. Louise Hecker
💡 What they do: Associate Professor of Medicine
💡 Company: Baylor College of Medicine
💡 Noteworthy: Known for groundbreaking research on how psilocybin affects cellular aging, healthspan, and tissue repair in both cells and animal models.
💡 Guest Company Website: https://www.bcm.edu/people-search/louise-hecker-175346
Episode highlights:
[00:00:00]: Introduction
[00:00:18]: Scientific Journey and Focus on Aging
[00:01:27]: Transition from Regeneration to Aging Research
[00:02:53]: Decline of Regeneration with Age
[00:03:43]: Motivation for Studying Psilocybin and Aging
[00:04:13]: Initial Curiosity and Literature Review on Psilocybin
[00:05:38]: Psilocybin’s Broad Clinical Applications
[00:06:19]: Hypothesis: Psilocybin’s Lasting Effects Linked to Aging
[00:07:14]: Defining Psilocybin and Its Effects
[00:08:25]: Legal Status and Research Barriers
[00:09:57]: Resurgence in Psilocybin Research and Regulatory Changes
[00:10:40]: Experimental Design: Dosing and Model Selection
[00:11:54]: Regulatory Hurdles in Acquiring Psilocybin
[00:13:08]: Initiating Experiments and Early Findings
[00:14:30]: Cellular Lifespan Extension Results
[00:15:17]: Quantifying Cellular Effects and Replication
[00:16:23]: Addressing Potential Cancer Concerns
[00:17:10]: Hallmarks of Aging and Cellular Markers
[00:18:44]: Telomere Length and DNA Protection
[00:19:52]: Organ-Specific Effects and Ongoing Research
[00:22:05]: Transition to Mouse Studies
[00:23:44]: Designing the Mouse Longevity Study
[00:26:28]: Results: Survival and Phenotypic Changes in Mice
[00:28:36]: Translating Mouse Findings to Humans
[00:30:09]: Next Steps: Dosing, Protocols, and Human Relevance
[00:32:26]: Omics Profiling and Organ-Specific Protection
[00:33:54]: Safety, Risks, and Human Studies
[00:35:13]: Comparing Psilocybin to Other Longevity Interventions
[00:37:00]: Implementation Challenges and Future Research Directions
[00:40:00]: Advice for Biohackers and Caution on Self-Experimentation
[00:42:29]: Funding, Research Priorities, and the Future of Psychedelic Research
[00:43:58]: Rapid-Fire Questions: Aging Misconceptions and Research Priorities
[00:46:11]: Social Connection and Long-Term Health
[00:48:50]: Key Takeaways and Closing Thoughts
[00:51:26]: Outro and Farewell
Key Insights
Psilocybin Shows Potential to Extend Lifespan and Reduce Aging Markers
Psilocybin, the active compound in psychedelic mushrooms, has emerged as a promising candidate for supporting healthy aging. In both human cells and aging mice, Dr. Louise Hecker observed that psilocybin extended cellular lifespan and improved markers tied to aging. Treated cells maintained longer telomeres, reduced oxidative stress, and better DNA repair compared to untreated controls. In animal models, regular dosing not only improved survival rates but also reversed visible signs of aging, such as fur regrowth and color restoration. These benefits appeared across various organs, not just the brain. For anyone interested in longevity, these early findings suggest that psilocybin may one day offer a new approach to slowing age-related decline. However, more research is needed to understand dosing, safety, and possible risks before considering real-world use.
Pursuing Aging Itself May Yield Bigger Health Gains Than Targeting Single Diseases
Traditional medical research often focuses on treating individual age-related diseases, like Alzheimer’s or fibrosis. Yet, the science of aging points to a different strategy: slow down the aging process itself to improve overall health. By targeting the biological hallmarks that drive aging, it may be possible to delay or prevent a wide range of chronic conditions at once. This approach could boost both lifespan and healthspan, meaning more years lived in good health. Research on compounds like psilocybin encourages a shift in thinking, away from disease silos and toward the root mechanisms of aging. For those invested in long-term wellness, this means supporting research and therapies that aim at the biology of aging, not just disease symptoms.
Safety and Dosing Require Caution Before Real-World Use
Early research on psilocybin and aging shows strong promise, but also highlights the need for caution. Dr. Hecker stresses that more work is needed before anyone considers psilocybin as an anti-aging therapy. Key unknowns include the safest and most effective dose, how often it should be used, and the long-term effects or risks, especially with repeated use. While clinical trials so far suggest psilocybin can be safe under controlled conditions, the lack of data on long-term or high-frequency use means it’s not ready for mainstream adoption. Those interested in biohacking or self-experimentation should wait for more evidence and guidance from ongoing research. Patience now may prevent harm and lead to smarter, safer interventions in the future.
Curiosity Sparks New Research on Psilocybin and Aging
A casual conversation with a friend led to a deep dive into the science of psilocybin and its effects on aging. The realization that one compound could influence many diseases prompted a shift in research focus. This moment set the stage for experiments exploring psilocybin’s broader biological impact, asking not just how the compound works in the brain, but whether it could affect the body’s aging process itself. Curiosity and open-mindedness played a key role in launching this line of inquiry, underlining the value of asking new questions in science.
“I thought I was going to be reading for 15 minutes, and four hours later I was still reading, and I just couldn’t get enough of this topic. I was so fascinated. Psilocybin is an interesting drug... Someone had put this idea out there, that maybe the way that it’s having these long-term impacts is that it’s having an impact on aging. And that can lead to a number of different impacts, right? So I thought, I study aging, and I can test that, and that’s really where everything started.”
Running Experiments: Psilocybin’s Effects in Cells and Mice
Setting up studies to test psilocybin’s effects wasn’t easy. Regulatory hurdles and slow processes made it difficult to acquire the compound for research. But persistence paid off, and the team ran experiments on human cells and mice. These studies revealed that psilocybin could extend cell lifespan and produce measurable differences in aging markers. The excitement grew as similar effects were seen in different cell types, and the research moved from cells to animals. These practical steps and careful design highlight the importance of methodical science, even when pursuing new ideas.
“It was a long process, probably about a year before, from the time that I had this idea and went into the lab to order it to the time I actually initiated an experiment... And then what we found was that in a dose-dependent way... led to this dramatic increase in cellular life extension. So cells lived much longer in a dose-dependent way. And that was the first major result.”
Animal Studies Reveal Systemic Impact and Visible Change
Experiments in aging mice showed striking results. Regular psilocybin dosing improved survival rates and produced visible changes, reversing bald spots and restoring hair color. The mice looked healthier and survived longer than controls. These findings went beyond expectations, suggesting that psilocybin’s effects are not limited to the brain but extend to many organs and systems. The research also revealed differences in how various tissues respond, opening up new questions and directions for future study.
“When 50% of the vehicle mice died, 80% of the psilocybin treated mice were still thriving and surviving. Not only did they have this dramatic increase in survival, but the mice phenotypically looked better. They had... bald spots, gray hair, and they were starting to show these aging phenotypes at the start of the experiment. And interestingly, and probably the most surprising result is that psilocybin treatment reversed some of these phenotypes. So bald spots grew back hair, white hair grew back black.”
Rethinking Aging: Target the Process, Not Just Diseases
The conversation turned to bigger questions about how science approaches aging. Instead of focusing only on individual age-related diseases, there’s value in tackling the aging process itself. By slowing aging, it may be possible to prevent or delay many diseases at once, improving both lifespan and healthspan. This highlights the need for research and funding to shift toward understanding and modifying the root causes of aging, rather than just its symptoms. This approach could change not only how we treat disease, but how we think about health across the lifespan.
“We haven’t traditionally prioritized studying aging itself and longevity and health span, which... are surrogate markers for, I think if you can improve lifespan, then I think that’s a good indication you’re going to improve health span, which is what I’m after. And if you can improve health span, then you’re going to improve age-related disease outcomes... We may have a better chance to improve human health by targeting aging itself versus targeting age-related diseases.”
For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast